Publikationen von Matthias L. Schroeter
Alle Typen
Zeitschriftenartikel (206)
2011
Zeitschriftenartikel
6 (3), e18111 (2011)
Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia. PLoS One
Zeitschriftenartikel
49 (3), S. 409 - 424 (2011)
S100B protein in neurodegenerative disorders. Clinical Chemistry and Laboratory Medicine
Zeitschriftenartikel
54 (1), S. 337 - 343 (2011)
Investigating brain response to music: A comparison of different fMRI acquisition schemes. NeuroImage 2010
Zeitschriftenartikel
134 (1-3), S. 32 - 38 (2010)
Glial pathology is modified by age in mood disorders - A systematic meta-analysis of serum S100B in vivo studies. Journal of Affective Disorders
Zeitschriftenartikel
182 (3), S. 274 - 280 (2010)
Executive and behavioral deficits share common neural substrates in frontotemporal lobar degeneration - A pilot FDG-PET study. Psychiatry Research: Neuroimaging
Zeitschriftenartikel
49 (2), S. 1490 - 1495 (2010)
Differential effects of global and cerebellar normalization on detection and differentiation of dementia in FDG-PET studies. NeuroImage
Zeitschriftenartikel
74 (4), S. 306 - 312 (2010)
Resuscitating the heart but losing the brain: Brain atrophy in the aftermath of cardiac arrest. Neurology
Zeitschriftenartikel
2010, 780645 (2010)
Mood disorders are glial disorders: Evidence from in vivo studies. Cardiovascular Psychiatry and Neurology
Zeitschriftenartikel
48 (1), S. 185 - 193 (2010)
Traumatic brain injury affects the frontomedian cortex: An event-related fMRI study on evaluative judgments. Neuropsychologia
Zeitschriftenartikel
2010, S. 480707 (2010)
S100B serum levels in schizophrenia are presumably related to visceral obesity and insulin resistance. Cardiovascular Psychiatry and Neurology
Zeitschriftenartikel
35 (2), S. 321 - 324 (2010)
S100B serum levels are closely correlated with body mass index: An important caveat in neuropsychiatric research. Psychoneuroendocrinology
Zeitschriftenartikel
167 (4), S. 1025 - 1031 (2010)
Haloperidol and clozapine decrease S100B release from glial cells. Neuroscience
Zeitschriftenartikel
15 (1), S. 3 - 4 (2010)
Elevated S100B levels in schizophrenia are associated with insulin resistance. Molecular Psychiatry 2009
Zeitschriftenartikel
47 (4), S. 1196 - 1206 (2009)
Neural correlates of Alzheimer's disease and mild cognitive impairment: A systematic and quantitative meta-analysis involving 1,351 patients. NeuroImage
Zeitschriftenartikel
173 (3), S. 190 - 195 (2009)
Right prefrontal brain activation due to stroop interference is altered in attention-deficit hyperactivity disorder - A functional near-infrared spectroscopy study. Psychiatry Research
Zeitschriftenartikel
167 (1-2), S. 66 - 72 (2009)
Neuron-specific enolase is unaltered whereas S100B is elevated in serum of patients with schizophrenia – Original research and meta-analysis. Psychiatry Research
Zeitschriftenartikel
34 (5), S. 603 - 605 (2009)
Superficial siderosis of the central nervous system - Treatment with steroids? Journal of Clinical Pharmacy and Therapeutics
Zeitschriftenartikel
14 (3), S. 235 - 237 (2009)
Elevated serum levels of the glial marker protein S100B are not specific for schizophrenia or mood disorders. Molecular Psychiatry 2008
Zeitschriftenartikel
110 (10), S. 1054 - 1057 (2008)
Cognitive dysfunction, urinary retention, and a lesion in the thalamus - beware of possible toxocariasis of the central nervous system. Clinical Neurology and Neurosurgery
Zeitschriftenartikel
21 (1), S. 52 - 54 (2008)
Aerophagia and belching following Herpes simplex encephalitis. Cognitive and Behavioral Neurology